Comparison of three commercial molecular assays for detection of rifampin and isoniazid resistance among Mycobacterium tuberculosis isolates in a high-HIV-prevalence setting
JavaScript is disabled for your browser. Some features of this site may not work without it.
We are excited to announce that the repository will soon undergo an upgrade, featuring a new look and feel along with several enhanced features to improve your experience. Please be on the lookout for further updates and announcements regarding the launch date. We appreciate your support and look forward to unveiling the improved platform soon.
| dc.contributor.author | Strydom, Kathy-Anne
|
|
| dc.contributor.author | Ismail, Farzana
|
|
| dc.contributor.author | Matabane, M.M.Z.
|
|
| dc.contributor.author | Onwuegbuna, O.
|
|
| dc.contributor.author | Omar, Shaheed Vally
|
|
| dc.contributor.author | Ismail, Nabila
|
|
| dc.date.accessioned | 2015-12-04T05:18:33Z | |
| dc.date.issued | 2015-09 | |
| dc.description.abstract | In a head to head comparison of the MTBDRplus Version 2.0 (Hain Lifescience), Xpert® MTB/RIF (Cepheid) and the Anyplex™ MTB/NTM (Seegene) assays we demonstrate equal sensitivity (59/61; 96.7%) and specificity (53/54; 98.1%) for detecting rifampicin resistance with further analysis of discordances. The Xpert does not detect Isoniazid resistance while Anyplex showed high false positivity. | en_ZA |
| dc.description.embargo | 2016-03-31 | |
| dc.description.librarian | hb2015 | en_ZA |
| dc.description.sponsorship | National Health Laboratory Services | en_ZA |
| dc.description.uri | http://jcm.asm.org | en_ZA |
| dc.identifier.citation | Strydom, KA, Ismail, F, Matabane, MMZ, Onwuegbuna, O, Omar, SV & Ismail, N 2015, 'Comparison of three commercial molecular assays for detection of rifampin and isoniazid resistance among Mycobacterium tuberculosis isolates in a high-HIV-prevalence setting', Journal of Clinical Microbiology, vol. 53, no. 9, pp. 3032-3034. | en_ZA |
| dc.identifier.issn | 0095-1137 (print) | |
| dc.identifier.issn | 1098-660X (online) | |
| dc.identifier.other | 10.1128/JCM.01691-15 | |
| dc.identifier.uri | http://hdl.handle.net/2263/51054 | |
| dc.language.iso | en | en_ZA |
| dc.publisher | American Society for Microbiology | en_ZA |
| dc.rights | © 2015. American Society for Microbiology. All Rights Reserved. | en_ZA |
| dc.subject | Rifampicin | en_ZA |
| dc.subject | Isoniazid | en_ZA |
| dc.subject | Mycobacterium tuberculosis | en_ZA |
| dc.subject | High HIV prevalence setting | en_ZA |
| dc.title | Comparison of three commercial molecular assays for detection of rifampin and isoniazid resistance among Mycobacterium tuberculosis isolates in a high-HIV-prevalence setting | en_ZA |
| dc.type | Postprint Article | en_ZA |
